Synthesis, pharmacology, and clinical trial of the riboflavine analogue, sodium-6, 7-dimethyl-9-(2'-hemisuccinoxyethyl)-isoalloxazine, U-6538.
D000970:Antineoplastic Agents; D005415:Flavins; D006801:Humans; D009930:Organic Chemicals; D012256:Riboflavin / Q000031:analogs & derivatives; D012964:Sodium
D000970:Antineoplastic Agents; D005415:Flavins; D009930:Organic Chemicals; C008173:isoalloxazine; D012964:Sodium; D012256:Riboflavin
CYTOTOXIC DRUGS; VITAMIN B2/related compounds